Showing 1 - 20 results of 129 for search '(serology OR neurology)', query time: 0.09s Refine Results
  1. 1

    The neurological consequences of contracting COVID-19 by Aknin, LB, De Neve, JE, Dunn, EW, Fancourt, DE, Goldberg, E, Helliwell, JF, Jones, SP, Karam, E, Layard, R, Lyubomirsky, S, Rzepa, A, Saxena, S, Thornton, EM, VanderWeele, TJ, Whillans, AV, Zaki, J, Caman, O, Amor, YB

    Published 2021
    “…Since this first detection, research has indicated that people contracting the virus may suffer neurological and mental disorders and deficits, in addition to the respiratory and other organ challenges caused by COVID-19. …”
    Journal article
  2. 2

    Serological prevalence of leptospiral infection in domestic animals in West Malaysia by Bahaman, A. R., Ibrahim, A. L., Adam, H.

    Published 1987
    “…A cross-sectional serological survey of domestic animals in West Malaysia revealed that 25·5% of the animals examined had agglutinating antibodies to one or more antigens belonging to Leptospira interrogans. …”
    Get full text
    Article
  3. 3
  4. 4

    Paraneoplastic neurological syndromes: a practical approach to diagnosis and management by Binks, S, Uy, C, Honnorat, J, Irani, SR

    Published 2021
    “…Paraneoplastic neurological syndromes (PNS) are the immune-mediated effects of a remote cancer and are characterised by an autoantibody response against antigens expressed by the tumour. …”
    Journal article
  5. 5
  6. 6
  7. 7

    Epstein-Barr viral latent and early antigen serology in nasopharyngeal carcinoma by Tan, Timothy Ter Ming.

    Published 2008
    “…Clinically, it can be detected by an experienced medical practitioner using fibreoptic endoscopy, computer-assisted tomography or through serological tests. Serological testing detects the presence of specific antibodies to the Epstein-Barr virus, which is a crucial aetiological factor in the pathogenesis of the disease. …”
    Get full text
    Thesis
  8. 8

    Going ‘meta’: a systematic review of metacognition and functional neurological disorder by Sadnicka, A, Strudwick, A, Grogan, JP, Manohar, S, Nielsen, G

    Published 2025
    “…In functional neurological disorder (FND), there is a fundamental disconnect between an apparently intact nervous system and the individuals’ ability to consistently perform motor actions, perceive sensory signals and/or access effective cognition. …”
    Journal article
  9. 9
  10. 10

    Toward curing neurological autoimmune disorders: biomarkers, immunological mechanisms, and therapeutic targets by Segal, Y, Soltys, J, Clarkson, BDS, Howe, CL, Irani, SR, Pittock, SJ

    Published 2025
    “…Autoimmune neurology is a rapidly expanding field driven by the discovery of neuroglial autoantibodies and encompassing a myriad of conditions affecting every level of the nervous system. …”
    Journal article
  11. 11
  12. 12
  13. 13

    Using cluster analysis to reconstruct dengue exposure patterns from cross-sectional serological studies in Singapore by Sangkaew, Sorawat, Tan, Li Kiang, Ng, Lee Ching, Ferguson, Neil M., Dorigatti, Ilaria

    Published 2021
    “…We analysed serotype-specific antibody levels obtained by PRNT in two serological surveys conducted in Singapore in 2009 and 2013 using cluster analysis, a machine learning technique that was used to identify the most common histories of DENV exposure. …”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C by Maze, EA, Booth, G, Limon, G, Belij-Rammerstorfer, S, Tchakarova, SR, Alexandrov, T, Browning, C, Wilsden, G, Ludi, AB, Charleston, B, Lambe, T

    Published 2025
    “…Cross-reactivity to viruses of the Orthonairovirus genus can potentially interfere with serological assays when employed for serosurveillance in regions where two or more genus members overlap in their distribution. …”
    Journal article
  19. 19

    The WHO Mental Health Gap Action Programme for mental, neurological, and substance use conditions: the new and updated guideline recommendations by Brohan, E, Chowdhary, N, Dua, T, Barbui, C, Thornicroft, G, Kestel, D

    Published 2023
    “…The WHO Mental Health Gap Action Programme (mhGAP) guideline update reflects 15 years of investment in reducing the treatment gap and scaling up care for people with mental, neurological, and substance use (MNS) conditions. It was produced by a guideline development group and steering group, with support from topic experts, using quantitative and qualitative evidence and a systematic review of use of mhGAP. 90 recommendations from the 2015 guideline update were validated and endorsed for use in their current format. …”
    Journal article
  20. 20